Since 2013, the company has enjoyed substantial development leverage as a result of industry and technology partnerships and the financial backing of France’s National Research Agency (Agence Nationale de Recherche), French public investment bank Bpifrance, the General Investment Commission (Commissariat général à l’investissement) and its own private shareholders. It is majority owned by Dominique DUVAUCHELLE via Parvallis and is governed by a board of directors, of which two thirds are independent.
A multidisciplinary and scientific top-class team is at work and as a result has developed a proprietary portfolio. METABOLIUM’s efforts have been rewarded by the international recognition of four patent families. Our company is located at the BIOCITECH technology park for life sciences in Romainville, near Paris